📊 MBBC Key Takeaways
Is Marathon Bancorp, Inc. /MD/ (MBBC) a Good Investment?
Marathon Bancorp demonstrates impressive top-line growth with 58% revenue expansion and 129% EPS growth YoY, but fundamental profitability metrics remain deeply concerning. Interest coverage of 0.7x indicates operating income cannot cover interest expenses, while ROE of 3.0% and ROA of 0.6% are well below industry standards, suggesting the institution has not yet established sustainable banking economics.
Marathon Bancorp is showing clear year-over-year earnings acceleration, with revenue, net income, EPS, and free cash flow all improving meaningfully in the latest period. However, absolute profitability remains modest for a bank, as reflected in low ROE and ROA, so the fundamentals support cautious optimism rather than a strongly bullish view.
Why Buy Marathon Bancorp, Inc. /MD/ Stock? MBBC Key Strengths
- Strong revenue growth of 58.1% YoY demonstrates scaling momentum
- Exceptional EPS growth of 128.6% YoY shows improving earnings power
- Positive free cash flow of $2.0M with 22.4% FCF margin indicates operational cash generation
- Operating margin of 19.8% reflects cost discipline and efficiency
- Revenue and net income are growing rapidly year over year, indicating improving operating momentum
- Positive operating cash flow and strong free cash flow conversion support earnings quality
- Balance sheet appears conservatively funded with no reported long-term debt and a solid equity base
MBBC Stock Risks: Marathon Bancorp, Inc. /MD/ Investment Risks
- Interest coverage of 0.7x critically low—operating income cannot cover interest expense, signaling profitability distress
- ROE of 3.0% and ROA of 0.6% far below banking sector standards, indicating poor capital deployment efficiency
- Net income of $1.4M relative to $249M asset base and $47.5M equity is minimal, suggesting immature or struggling operations
- Small scale with limited insider activity (4 Form 4 filings in 90 days) may reflect low management conviction
- ROE and ROA remain low, suggesting limited efficiency and weak returns on capital despite recent growth
- Interest coverage is thin, pointing to limited earnings cushion relative to interest burden
- A small asset base can make results more sensitive to credit costs, deposit shifts, or margin pressure
Key Metrics to Watch
- Interest coverage ratio—must improve above 1.0x for operational sustainability
- ROE trajectory—target 8-10%+ to validate sector-competitive returns
- Net interest margin and deposit funding costs—critical drivers of margin expansion
- Asset quality metrics and loan loss provisions—essential health indicators for financial institutions
- ROE and ROA improvement over the next several quarters
- Net interest margin and provision for credit losses
Marathon Bancorp, Inc. /MD/ (MBBC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The 22.4% free cash flow margin provides substantial flexibility for dividends, buybacks, and strategic investments. The current ratio below 1.0x warrants monitoring of short-term liquidity.
MBBC Profit Margin, ROE & Profitability Analysis
MBBC vs Finance Sector: How Marathon Bancorp, Inc. /MD/ Compares
How Marathon Bancorp, Inc. /MD/ compares to Finance sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Marathon Bancorp, Inc. /MD/ Stock Overvalued? MBBC Valuation Analysis 2026
Based on fundamental analysis, Marathon Bancorp, Inc. /MD/ has mixed fundamental signals relative to the Finance sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Marathon Bancorp, Inc. /MD/ Balance Sheet: MBBC Debt, Cash & Liquidity
MBBC Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Marathon Bancorp, Inc. /MD/'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.07 indicates the company is currently unprofitable.
MBBC Revenue Growth, EPS Growth & YoY Performance
Marathon Bancorp, Inc. /MD/ Dividends, Buybacks & Capital Allocation
MBBC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Marathon Bancorp, Inc. /MD/ (CIK: 0001835385)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MBBC
What is the AI rating for MBBC?
Marathon Bancorp, Inc. /MD/ (MBBC) has a Combined AI Rating of HOLD from Claude (HOLD) and ChatGPT (HOLD) with 70% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are MBBC's key strengths?
Claude: Strong revenue growth of 58.1% YoY demonstrates scaling momentum. Exceptional EPS growth of 128.6% YoY shows improving earnings power. ChatGPT: Revenue and net income are growing rapidly year over year, indicating improving operating momentum. Positive operating cash flow and strong free cash flow conversion support earnings quality.
What are the risks of investing in MBBC?
Claude: Interest coverage of 0.7x critically low—operating income cannot cover interest expense, signaling profitability distress. ROE of 3.0% and ROA of 0.6% far below banking sector standards, indicating poor capital deployment efficiency. ChatGPT: ROE and ROA remain low, suggesting limited efficiency and weak returns on capital despite recent growth. Interest coverage is thin, pointing to limited earnings cushion relative to interest burden.
What is MBBC's revenue and growth?
Marathon Bancorp, Inc. /MD/ reported revenue of $8.8M.
Does MBBC pay dividends?
Marathon Bancorp, Inc. /MD/ does not currently pay dividends.
Where can I find MBBC SEC filings?
Official SEC filings for Marathon Bancorp, Inc. /MD/ (CIK: 0001835385) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MBBC's EPS?
Marathon Bancorp, Inc. /MD/ has a diluted EPS of $0.53.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is MBBC a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Marathon Bancorp, Inc. /MD/ has a HOLD rating with 70% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is MBBC stock overvalued or undervalued?
Valuation metrics for MBBC: ROE of 3.0% (sector avg: 12%), net margin of 16.3% (sector avg: 25%). Compare these metrics with sector averages to assess valuation.
Should I buy MBBC stock in 2026?
Our dual AI analysis gives Marathon Bancorp, Inc. /MD/ a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MBBC's free cash flow?
Marathon Bancorp, Inc. /MD/'s operating cash flow is $2.0M, with capital expenditures of $37.0K. FCF margin is 22.4%.
How does MBBC compare to other Finance stocks?
Vs Finance sector averages: Net margin 16.3% (avg: 25%), ROE 3.0% (avg: 12%), current ratio N/A (avg: 1.2).